ENTRY       D05263                      Drug
NAME        Onercept (USAN/INN)
FORMULA     C753H1156N228O247S25
EXACT_MASS  18143.7923
MOL_WEIGHT  18156.2401
SEQUENCE    DSVCPQGKYI HPQNNSICCT KCHKGTYLYN DCPGPGQDTD CRECESGSFT ASENHLRHCL
            SCSKCRKEMG QVEISSCTVD RDTVCGCRKN QYRHYWSENL FQCFCCSLCL NGTVHLSCQE
            KQNTVCTCHA GFFLRENECV SCSNCKKSLE CTKLCLPQIE N
            (Disulfide bridge: 4-18, 19-32, 22-41, 44-59, 62-77, 65-85, 87-103, 106-118, 109-126, 128-139, 142-151, 145-155)
  TYPE      Peptide
CLASS       Anti-inflammatory
             DG01985  Disease modifying anti-rheumatic drug (DMARD)
              DG01936  TNF inhibitor
EFFICACY    Anti-inflammatory, TNF-alpha inhibitor
COMMENT     fusion protein
            a recombinant human soluble type I TNF receptor (p55) [HSA:7132] [KO:K03158]
TARGET      TNF (TNFA, TNFSF2) [HSA:7124] [KO:K03156]
  PATHWAY   hsa04010(7124)  MAPK signaling pathway
            hsa04060(7124)  Cytokine-cytokine receptor interaction
            hsa04064(7124)  NF-kappa B signaling pathway
            hsa04350(7124)  TGF-beta signaling pathway
INTERACTION  
BRITE       Drug groups [BR:br08330]
             Anti-inflammatory
              DG01985  Disease modifying anti-rheumatic drug (DMARD)
               DG01936  TNF inhibitor
                D05263  Onercept
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Tumor necrosis factors
                TNF (TNFA, TNFSF2)
                 D05263  Onercept (USAN/INN)
DBLINKS     CAS: 199685-57-9
            PubChem: 47206972
///
